BECTON DICKINSON AND CO (1BDX.MI) Stock Price & Overview

BIT:1BDX • US0758871091

Current stock price

156.7 EUR
-8.05 (-4.89%)
Last:

The current stock price of 1BDX.MI is 156.7 EUR. Today 1BDX.MI is down by -4.89%.

1BDX.MI Key Statistics

Market Cap
44.915B
P/E
12.57
Fwd P/E
12.09
EPS (TTM)
12.47
Dividend Yield
2.37%

1BDX.MI Stock Performance

Today
-4.89%
1 Week
N/A
1 Month
N/A
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

1BDX.MI Stock Chart

BECTON DICKINSON AND CO / 1BDX Daily stock chart

1BDX.MI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 1BDX.MI.


Chartmill TA Rating
Chartmill Setup Rating

1BDX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1BDX.MI. While 1BDX.MI is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1BDX.MI Earnings

On November 6, 2025 1BDX.MI reported an EPS of 3.96 and a revenue of 5.89B. The company missed EPS expectations (-0.05% surprise) and missed revenue expectations (-1.22% surprise).

Next Earnings DateFeb 3, 2026
Last Earnings DateNov 6, 2025
PeriodQ4 / 2025
EPS Reported$3.96
Revenue Reported5.89B
EPS Surprise -0.05%
Revenue Surprise -1.22%

1BDX.MI Forecast & Estimates

19 analysts have analysed 1BDX.MI and the average price target is 190.9 EUR. This implies a price increase of 21.83% is expected in the next year compared to the current price of 156.7.

For the next year, analysts expect an EPS growth of 3.94% and a revenue growth 4.3% for 1BDX.MI


Analysts
Analysts72.63
Price Target190.9 (21.83%)
EPS Next Y3.94%
Revenue Next Year4.3%

1BDX.MI Groups

Sector & Classification

Index Membership

1BDX.MI Financial Highlights

Over the last trailing twelve months 1BDX.MI reported a non-GAAP Earnings per Share(EPS) of 12.47. The EPS increased by 9.57% compared to the year before.


Income Statements
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Industry RankSector Rank
PM (TTM) 7.68%
ROA 3.03%
ROE 6.61%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%3.94%
Sales Q2Q%8.33%
EPS 1Y (TTM)9.57%
Revenue 1Y (TTM)8.23%

1BDX.MI Ownership

Ownership
Inst Owners92.24%
Shares286.63M
Float284.96M
Ins Owners0.57%
Short Float %N/A
Short RatioN/A

About 1BDX.MI

Company Profile

1BDX logo image Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Company Info

IPO: 1963-09-25

BECTON DICKINSON AND CO

One Becton Drive

Franklin Lakes NEW JERSEY US

Employees: 74000

1BDX Company Website

1BDX Investor Relations

Phone: 12018476800

BECTON DICKINSON AND CO / 1BDX.MI FAQ

Can you describe the business of BECTON DICKINSON AND CO?

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


What is the current price of 1BDX stock?

The current stock price of 1BDX.MI is 156.7 EUR. The price decreased by -4.89% in the last trading session.


Does 1BDX stock pay dividends?

BECTON DICKINSON AND CO (1BDX.MI) has a dividend yield of 2.37%. The yearly dividend amount is currently 3.28.


How is the ChartMill rating for BECTON DICKINSON AND CO?

1BDX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the valuation of BECTON DICKINSON AND CO (1BDX.MI) based on its PE ratio?

The PE ratio for BECTON DICKINSON AND CO (1BDX.MI) is 12.57. This is based on the reported non-GAAP earnings per share of 12.47 and the current share price of 156.7 EUR.


How many employees does BECTON DICKINSON AND CO have?

BECTON DICKINSON AND CO (1BDX.MI) currently has 74000 employees.


What is the market capitalization of 1BDX stock?

BECTON DICKINSON AND CO (1BDX.MI) has a market capitalization of 44.91B EUR. This makes 1BDX.MI a Large Cap stock.